Column Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Column Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$1K	–	751
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	712
2021 Q4	$1K	Hold	3	–	–	﹤0.01%	772
2021 Q3	$1K	Hold	3	–	–	﹤0.01%	716
2021 Q2	$1K	Sell	3 -2	-40%	-$662	﹤0.01%	709
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	642
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	687
2020 Q3	$1K	Sell	5 -18	-78%	-$4.23K	﹤0.01%	675
2020 Q2	$4K	Buy	+23	New	+$3.74K	﹤0.01%	611

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Column Capital Advisors's ONC Position: Q2 2022 in Review

Column Capital Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.

Column Capital Advisors first reported a position in ONC in Q2 2020 and held it in 8 quarters. The position peaked at $4K in Q2 2020. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

Column Capital Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
Column Capital Advisors sold 3 BeOne Medicines Ltd shares in Q2 2022, an estimated $1K.
Column Capital Advisors first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 8 quarters.
Column Capital Advisors's BeOne Medicines Ltd position peaked at $4K in Q2 2020.
235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Column Capital Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.